TENNESSEE GUIDELINES FOR MANAGING CHRONIC PAIN
Choose the best possible answer for each question and mark your answers on the self-assessment answer sheet at the end of this book. There is a required score of 70% or better to receive a certificate of completion.
1. Schedule I Drugs:
6. Examples of functional goals for treatment of chronic, non-malignant pain with opioids may include:
A. Include benzodiazepines. B. Include opiates such as fentanyl.
A. Improved activities of daily living. B. Increased social participation. C. Return to work. D. All the above.
C. Are considered to have the highest risk for misuse. D. May be prescribed for 5 refills within a 6-month time period. 2. Tolerance refers to: A. The same dose of drug given repeatedly produces reduced biological response. B. Onset of withdrawal symptoms when medication is abruptly discontinued. C. Individuals prescribed controlled substances who allow other family members to take the controlled substance medications for medical purposes. D. Taking medication to feel euphoria. 3. A prescriber’s DEA license may be suspended or revoked for all the following EXCEPT: A. Revocation or suspension of a state medical license. B. Felony conviction related to Controlled Substances. C. False statements entered in the Controlled Substance application. D. Theft of controlled substances from the prescriber’s secured storage. 4. Inappropriate prescribing behavior of controlled substances may include: A. No logical relationship between the prescribed drug and medical condition. B. Lack of physical examination documentation in patient chart. C. Instructing patients to fill their medications at different pharmacies. D. All of the above.
7. Risk factors for opioid overdose include all the following EXCEPT: A. Recent release from jail or prison. B. Benzodiazepine use. C. Recent release from substance treatment program. D. Age >65 years old. 8. Regarding the Tennessee Controlled Substances Monitoring Database (CSMD): A. Two approved physician extenders may utilize the database to obtain relevant information to the practice site. B. Only prescribers of controlled substances are required to register with the CSMD. C. Data is collected only for Schedule I, II and III medications. D. Patient report data is limited only to medication name, dose and date prescription filled. 9. Benzodiazepines: A. Are included in Schedule II controlled substances. B. Should be avoided in combination with opioid medications. C. May be abruptly discontinued with no harm to patients. D. Include all the medications known as “Z-drugs”. 10. An example of a controlled substance that is FDA approved for treatment of Opioid Use Disorder (OUD) is: A. Diphenhydramine. B. Codeine. C. Methadone. D. Clonidine.
5. Prior to instituting opioid use for chronic, non- malignant pain, prescribers must consider:
A. Telemedicine appointments as an appropriate visit. B. Birth control for any woman of childbearing age. C. Elimination of pain as the primary goal of treatment. D. Which patients require urine drug testing.
19
Powered by FlippingBook